EU Teeth: Dental Care and Product Safety in the EU

The European Union regulates dental products and dental care more aggressively than most other regions, setting strict limits on everything from whitening gels to the metals in orthodontic brackets to the algorithms behind AI-assisted diagnostics. But the EU is not a single health system. It is 27 countries with wildly different levels of public dental coverage, dentist availability, and out-of-pocket costs. The result is a patchwork where product safety standards are among the tightest in the world, yet access to actual dental care varies enormously depending on where you live.

How the EU Regulates Dental Products

Dental materials used by professionals, such as filling composites, implants, and orthodontic wires, fall under the EU’s Medical Device Regulation (MDR), which replaced the older Medical Device Directive in 2021. The MDR requires manufacturers to demonstrate safety and performance before receiving a CE mark, the certification needed to sell products on the European market. The new rules significantly increase documentation requirements for both manufacturers and dentists. One consequence flagged by researchers is that smaller European companies face disproportionate regulatory burdens compared to their larger global competitors, and the MDR is expected to reduce the number of available products while pushing prices up.¹

Products that people buy themselves, like whitening strips and toothpastes containing active ingredients, are regulated as cosmetics under the EU Cosmetics Regulation. This dual-track system means the same substance can be governed by completely different rules depending on whether it is used in a dental clinic or sold in a pharmacy. A nano-hydroxyapatite toothpaste sits under cosmetics law; a hydroxyapatite bone graft used during implant surgery sits under the MDR. The distinction matters because the safety data required, the approval timelines, and the post-market surveillance obligations differ substantially between the two frameworks.

Teeth Whitening Restrictions

If you have ever wondered why the whitening products available in European shops seem weaker than what you can buy in the United States, the reason is a 2011 directive that took effect in late 2012. Under EU law, whitening products containing less than 0.1% hydrogen peroxide (present or released) can be sold directly to consumers. Products between 0.1% and 6% hydrogen peroxide are restricted to use by or sale through dental practitioners. Anything above 6% is outright banned.²

In practice, this means the over-the-counter whitening strips and pens sold in EU countries are far milder than many American products, which routinely contain 10% or more hydrogen peroxide equivalent. To get a meaningful clinical whitening treatment in Europe, you need to visit a dentist. Whether this is overly paternalistic or sensibly cautious depends on your perspective, but the regulation was driven by concerns about enamel damage and soft-tissue irritation from unsupervised high-concentration use.

Safety of Dental Filling Materials

One recurring concern among patients is whether the composite resins used for tooth-colored fillings release bisphenol A, a chemical that has drawn attention for its potential hormonal effects. The short answer is yes, small and varying amounts of BPA do leach from some dental composites, but the quantities appear to be negligible in the context of total daily exposure. The European Food Safety Authority estimated that dental sealants contribute roughly 0.001% of a person’s total BPA exposure from all sources, a figure well below safe intake thresholds.³ A separate review confirmed that while BPA leakage is detectable, critical levels are not evident, and that some composite ingredients can convert to BPA inside the mouth.⁴

The exposure is also largely acute rather than chronic. Most BPA release from a fresh filling happens within the first hour after placement, then drops off sharply. So while BPA in dental materials is real, the current scientific consensus across both European and American regulatory bodies is that modern composites do not pose a meaningful health risk on this front.

Metals in Orthodontic Appliances

Braces, bands, and archwires are typically made from stainless steel or nickel-titanium alloys, and both metals leach into saliva in measurable amounts. Research tracking nickel and titanium release in orthodontic patients found that concentrations in saliva peaked at about three months after placement, and that levels in urine also rose at three and six months. Even at peak release, the concentrations stayed within acceptable limits.⁵

An in vitro study that tested various brackets, bands, and wires similarly confirmed that heavy metal release from orthodontic materials falls well below typical dietary intake of those same metals. That said, the researchers recommended titanium brackets and tube attachments instead of traditional bands for patients with confirmed nickel or chromium allergies.⁶ The EU’s REACH regulation already restricts nickel release from items in prolonged contact with skin, and while orthodontic devices are classified as medical devices rather than consumer goods, the same safety philosophy applies.

Nano-Hydroxyapatite in Toothpaste

Nano-hydroxyapatite toothpastes have grown popular in Europe and Japan as a fluoride-free alternative for remineralization. The EU’s Scientific Committee on Consumer Safety (SCCS) reviewed the evidence and flagged a specific concern: needle-shaped nano-hydroxyapatite particles show potential toxic effects and should not be used in cosmetic products. For other particle shapes (rod-like, spherical), the SCCS said the available data was insufficient to draw a firm safety conclusion when used in oral products at concentrations up to 10%.⁷

This means that in the EU, the regulatory picture for nano-hydroxyapatite toothpastes is unsettled. Products on the market tend to use non-needle-shaped particles and concentrations within the range the SCCS examined, but the committee stopped short of declaring them safe. If you are choosing between fluoride and nano-hydroxyapatite toothpaste in Europe, it is worth knowing that fluoride toothpaste has decades of well-established evidence behind it, while nano-hydroxyapatite occupies a regulatory gray zone.

Fluoride Policy Across EU Countries

Unlike the United States, where community water fluoridation is widespread, most EU countries rely on fluoride toothpaste as the primary delivery vehicle. A comparative study of fluoride use across seven European countries found that Ireland was the outlier, with about 74% of its population receiving fluoridated water. In every other country studied, fluoride toothpaste, typically recommended in pea-sized amounts, was the main source. Supplement use varied considerably from country to country.⁸

Several EU nations have used fluoridated salt or fluoridated milk as community-level interventions instead of water fluoridation. Germany and France, for instance, have promoted fluoridated salt. The diversity of approaches reflects long-standing differences in public health philosophy and, in some cases, political opposition to water fluoridation. A review of fluorosis across the EU noted that multiple fluoride delivery vehicles are in use and that each country’s risk factors and dental health policies shape how much fluorosis occurs locally.⁹ The practical upshot for residents: your main fluoride exposure in most EU countries comes from your toothpaste, not your tap water.

Dental Implants and Biomaterial Choices

Titanium has been the gold standard for dental implants for decades, but zirconia (ceramic) implants have gained traction in Europe, partly driven by patients who want a metal-free option. A head-to-head comparison of titanium and zirconia implants in animal models found that both materials showed good biocompatibility and direct bone-to-implant contact. Zirconia implants exhibited a slight delay in integration: at four weeks, bone contact was about 59% for zirconia versus 64% for titanium, and at twelve weeks it was roughly 67% versus 74%. The difference was not statistically significant.¹⁰

Zirconia implants are CE-marked and widely available in Europe. They appeal to patients concerned about metal sensitivities or who prefer the white color for aesthetic reasons, particularly in the front of the mouth. The trade-off is that zirconia implants tend to come in one-piece designs rather than the modular two-piece systems common with titanium, which limits flexibility during placement and restoration. For most patients, both materials are safe and effective. The choice comes down to clinical circumstances and personal preference.

Chlorhexidine Use and Its Side Effects

Chlorhexidine mouthwash is one of the most commonly prescribed antiseptics in European dentistry, used after surgery, during periodontal treatment, and to manage plaque. It works, but it is not without downsides. Even at the low concentrations used therapeutically (0.06% to 0.2%), side effects reported over a 21-day course include taste changes, numbness of the mouth and tongue, dry mouth, and tooth discoloration. The staining is the single most common reason patients stop using it. Higher concentrations (0.12% and 0.2%) were associated with significantly more taste alteration and numbness compared to 0.06%, though severe reactions like mucosal erosion were not reported.¹¹

A narrative review of chlorhexidine’s uses found evidence supporting short-term adjunctive use for managing plaque, reducing gingivitis symptoms, and preventing dry socket after extractions. However, the evidence for its effectiveness against periodontitis, dental caries, peri-implantitis, and aerosolized viruses was less certain. The review also raised the issue of antimicrobial resistance to antiseptic agents as a concern with widespread use, along with rare but potentially fatal allergic reactions.¹² If your dentist prescribes chlorhexidine, it is generally safe for short-term use, but it is not a substitute for daily brushing and flossing, and long-term use without professional guidance is not advisable.

Oral Health Disparities Across EU Countries

The EU may harmonize product safety, but it does not harmonize dental care systems. The variation between countries is striking. Across 34 European countries, the median rate of untreated cavities was about 35%, meaning roughly one in three people is walking around with at least one untreated cavity. Dentist availability ranged from about 1 per 10,000 people to nearly 18 per 10,000. Per capita dental spending ranged from around $10 to nearly $500, and the share covered by public funds varied from less than 1% to over 70%.¹³

Edentulism, the complete loss of natural teeth, also varies widely. A study tracking trends from 1990 to 2021 found that Finland saw substantial decreases in tooth loss prevalence, while Sweden saw increases. Inequality between countries narrowed slightly over three decades, but significant gaps remain. Men consistently showed greater inequality in edentulism rates than women across EU member states.¹⁴

What Public Dental Coverage Actually Looks Like

Most EU countries cover emergency dental care, extractions, and basic fillings for acute pain. Beyond that, things diverge quickly. Root canal treatment, periodontal care, and prosthetic work such as crowns and dentures often require significant cost-sharing or are excluded entirely from public coverage. Even routine check-ups are limited to one per year in many countries.¹⁵

For children, the picture is similarly uneven. A comparative study of six European countries found that in nations without universal dental coverage, such as Ireland and Spain, the private sector fills the gap, resulting in substantial out-of-pocket expenses for families. Even in countries with publicly funded systems, practical barriers like geographic access and long wait times can undermine the coverage on paper.¹⁶ The cross-border care directive technically allows EU citizens to seek dental treatment in another member state and apply for reimbursement through their home social security system, but in practice this is complex and underused for routine dental work.¹⁷

Children’s Preventive Dental Programs

Brief dental interventions aimed at preventing cavities in children are available in 25 of the 27 EU countries, but these are mostly limited to basic oral health education. Only about a third of responding countries had formal caries monitoring systems in place.¹⁸ School dental screening programs exist in fewer than half of surveyed EU nations as part of public dental care, and free public screening for preschool children was available nationwide in only 8 of 26 responding countries. Where screening does exist, it is usually limited to certain age groups.¹⁹

The gap between what public health experts recommend and what is actually implemented is noticeable. Universal school dental screening is widely endorsed as a way to catch problems early, especially in children from lower-income families who are less likely to visit a private dentist. Yet most EU countries have not built this into their systems on a nationwide scale, relying instead on parental initiative to get children seen.

Antibiotic Prescribing in EU Dentistry

Antimicrobial resistance is a growing concern across European healthcare, and dentistry is not exempt. In Belgium, the total volume of antibiotics prescribed by dentists rose by nearly 14% over the past decade, and the publication of national prescribing guidelines in 2020 did not meaningfully change the proportion of prescriptions that matched recommendations.²⁰ This pattern is not unique to Belgium. A systematic review of survey-based studies found that across Europe, roughly 61% of dental professionals routinely prescribe prophylactic antibiotics around implant placement. The most common approach was perioperative dosing (before and during surgery), followed by postoperative-only regimens.²¹

Whether prophylactic antibiotics for routine implant surgery are necessary at all remains debated. Many guidelines suggest they are not needed for healthy patients undergoing straightforward implant placement, yet the habit persists. The disconnect between guidelines and practice is a theme across European dental antibiotic stewardship efforts, and closing that gap is one of the EU’s priorities under its broader action plan on antimicrobial resistance.

Direct-to-Consumer Aligners and Adverse Events

Clear aligners shipped directly to consumers without in-person dental oversight have become a global phenomenon, and their safety has drawn regulatory attention in Europe. A study of the FDA’s adverse event database identified 104 reports specifically related to direct-to-consumer aligners. Among the reported problems, roughly 41% involved bite issues, 30% involved facial or jaw pain, and 27% involved some form of periodontal damage. About 69% of the patients who experienced an adverse event ended up seeking care from a dentist unaffiliated with the aligner company.²²

The EU classifies orthodontic devices as medical devices under the MDR, which means aligners, including those sold remotely, must meet CE marking requirements. Several European dental professional organizations have pushed back against remote-only orthodontic treatment, arguing that moving teeth without regular clinical examination creates risks that consumers are poorly equipped to evaluate themselves. The trend toward AI-assisted treatment planning in this space adds another layer of complexity, with the EU AI Act expected to affect how such diagnostic tools are validated and deployed.²³

Dentist Mobility Across Borders

One feature of the EU’s single market is the mutual recognition of professional qualifications, which allows dentists trained in one member state to practice in another. This has been a significant source of workforce supply, particularly for countries facing shortages. The movement of dentists across borders, especially into the United Kingdom before Brexit, provided a substantial boost to staffing levels. But mutual recognition depends on the assumption that dental education across EU countries produces equivalently competent graduates, and this assumption has come under scrutiny. Professional regulators need assurance that dentists who qualified elsewhere have the knowledge, skills, and clinical experience to practice safely, and the considerable variation in undergraduate dental curricula across Europe makes that assurance harder to guarantee.²⁴

For patients, this mobility cuts both ways. It means your dentist may have trained in a very different educational system from the one in your country, but it also means that workforce shortages can be alleviated more quickly than in systems without free movement. Some member states have begun supplementing mutual recognition with additional competency checks or language requirements, trying to balance free movement with patient safety concerns.